神经精神症状与阿尔茨海默病及相关痴呆神经病理诊断的关联
该回顾性队列研究分析美国国家阿尔茨海默病协调中心第10版数据库中1808例脑组织,评估阿尔茨海默病及相关痴呆的神经病理诊断与神经精神症状问卷12个症状域的关联。结果显示海马硬化与冷漠和脱抑制增加相关,路易体病与阿尔茨海默病共存时幻觉更常见,神经病理严重程度与神经精神症状严重程度相关。
要点
- 海马硬化与冷漠增加(OR 2.60)和脱抑制增加(OR 2.15)相关。
- 阿尔茨海默病伴路易体病者幻觉比例为31.5%,高于单纯路易体病者的19.6%。
- 路易体病病理从脑干到新皮层越严重,幻觉增加越明显。
核心结论
- 路易体病与阿尔茨海默病共存的患者幻觉患病率高于单纯路易体病患者。
- 行为变异型额颞叶变性的冷漠和脱抑制神经精神症状标准在本研究中得到支持。
- 海马硬化中冷漠和脱抑制增加的发现在本研究中值得进一步研究。
- 神经病理严重程度与神经精神症状严重程度相关,提示神经精神症状可能反映潜在的阿尔茨海默病及相关痴呆病理。
研究设计与样本
- 该研究为回顾性队列研究,评估美国国家阿尔茨海默病协调中心第10版收集中39个中心的1808例脑组织。
- 研究对象为每年接受神经精神症状问卷(NPIQ)评估的参与者,脑组织尸检诊断包括阿尔茨海默病、路易体病、脑淀粉样血管病、额颞叶变性、脑血管病、海马硬化和无已知病理。
- 尸检数据采集于2012年1月至2018年1月,去标识化后编入公开可用的第10版数据库,数据分析时间为2021年2月至2021年8月。
主要发现
- 研究样本1808例成人平均(标准差)年龄为80.0(11.0)岁,其中男性987例(54.6%)。
- 冷漠是最常见的神经精神症状,在海马硬化患者中达到80%(254例中203例)。
- 与阿尔茨海默病相比,额颞叶变性与冷漠增加、脱抑制增加以及精神病和激越减少相关。
- 海马硬化与冷漠增加(比值比2.60;95%CI 1.86-3.66;错误发现率控制P<.001)和脱抑制增加(比值比2.15;95%CI 1.63-2.84;错误发现率控制P<.001)相关。
- 在纳入共病神经病理的多重回归分析中,主要发现保持不变;路易体病与幻觉增加相关,从脑干(β=0.23;95%CI 0.07-0.76;P=.02)到边缘系统(β=1.69;95%CI 1.27-2.27;P<.001)再到新皮层(β=4.49;95%CI 3.27-6.16;P<.001)病理。
关键数值与推荐
- 海马硬化与冷漠增加相关:比值比2.60(95%CI 1.86-3.66;错误发现率控制P<.001)。
- 海马硬化与脱抑制增加相关:比值比2.15(95%CI 1.63-2.84;错误发现率控制P<.001)。
- 路易体病与幻觉增加相关:脑干β=0.23(95%CI 0.07-0.76;P=.02)、边缘系统β=1.69(95%CI 1.27-2.27;P<.001)、新皮层β=4.49(95%CI 3.27-6.16;P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Understanding associations of Alzheimer disease (AD) and related dementias (ADRD) pathologies with common neuropsychiatric symptoms (NPS) may have implications for diagnosis and management. OBJECTIVE: To evaluate ADRD neuropathological diagnoses and NPS without consideration of clinical diagnosis. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study evaluated 1808 brains from 39 sites in the US National Alzheimer Coordinating Center v. 10 collection for participants among whom the Neuropsychiatric Inventory Questionnaire (NPIQ) was administered annually. Brain autopsy diagnoses of AD, Lewy body disease (LBD), cerebral amyloid angiopathy, frontotemporal lobar degeneration, cerebrovascular disease, hippocampal sclerosis, and no known pathology were examined. Autopsy data collected from January 2012 to January 2018 were deidentified and compiled into the publicly available v. 10 database. Data were analyzed from February 2021 to August 2021. MAIN OUTCOMES AND MEASURES: The primary outcome was NPIQ domain score, if present at any time point, and mean NPIQ domain score during follow-up was secondary. Associations of ADRD diagnoses with 12 NPIQ symptom domains were examined in regression analyses, correcting for multiple comparisons. RESULTS: The study sample of 1808 adults had a mean (SD) age of 80.0 (11.0) years, and 987 participants (54.6%) were male. Apathy was the most prevalent NPS, reaching 80% (203 of 254 individuals) in those with hippocampal sclerosis. Cerebrovascular disease showed few NPS associations. Frontotemporal lobar degeneration was associated with increased apathy, increased disinhibition, and decreased psychosis and agitation compared with AD. Hippocampal sclerosis was associated with increased apathy (odds ratio, 2.60; 95% CI; 1.86-3.66, false discovery rate controlled P < .001) and disinhibition (odds ratio, 2.15; 95% CI, 1.63-2.84; false discovery rate controlled P < .001). In multiple regression analyses that included concomitant neuropathologies, the main findings remained. More severe pathology was consistently associated with increased NPS (eg, LBD was associated with an increase in hallucinations from brain stem [β, 0.23; 95% CI, 0.07-0.76; P = .02] to limbic [β, 1.69; 95% CI, 1.27-2.27; P < .001] to neocortical [β, 4.49; 95% CI, 3.27-6.16; P < .001] pathology). Hallucinations were more common in participants with AD and LBD (168 of 534 [31.5%]) compared with those with AD without LBD (152 of 704 [21.6%]) and those with LBD without AD (23 of 119 [19.6%]). CONCLUSIONS AND RELEVANCE: In this cohort study of 1808 brains from the US National Alzheimer Coordinating Center, patients with LBD and AD showed a higher prevalence of hallucinations compared with those with LBD without AD. Neuropsychiatric symptom criteria of apathy and disinhibition in behavioral variant frontotemporal lobar degeneration were supported in this study. In hippocampal sclerosis, the findings of increased apathy and disinhibition merit further investigation. Severity of neuropathology was associated with NPS severity, indicating that NPS may reflect underlying ADRD pathology and highlighting the importance of diagnosing and treating NPS.
引用
- Devanand DP, Lee S, Huey ED, et al. Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias. JAMA Psychiatry. 2022. PMID: 35171235. doi:10.1001/jamapsychiatry.2021.4363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。